0000931059 false 0000931059 2021-12-03 2021-12-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares











TO SECTION 13 or 15(d) OF THE



Date of report (Date of earliest event reported): December 3, 2021


Rennova Health, Inc.

(Exact Name of Registrant as Specified in Its Charter)



(State or Other Jurisdiction of Incorporation)


001-35141   68-0370244
(Commission File Number)   (I.R.S. Employer Identification No.)


400 South Australian Avenue, Suite 800, West Palm Beach,
(Address of Principal Executive Offices)   (Zip Code)


(561) 855-1626
(Registrant’s Telephone Number, Including Area Code)




(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered under Section 12(b) of the Act:


Title of each class   Trading Symbol   Name of each exchange on which registered
None   None   None


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐







Item 1.01. Entry into a Material Definitive Agreement.


On December 10, 2021, Rennova Health, Inc. (the “Company”) completed the second closing of its offering of shares of Series O Convertible Redeemable Preferred Stock (the “Series O Preferred Stock”). The offering was pursuant to the terms of the previously-announced Securities Purchase Agreement, dated as of October 28, 2021 (the “Purchase Agreement”), between the Company and certain existing institutional investors of the Company.


The Purchase Agreement provided for the issuance of up to 4,400 shares of Series O Preferred Stock. The first closing for 2,200 shares of Series O Preferred Stock occurred on October 28, 2021. The Company received proceeds of $2,000,000 for the second closing and issued an additional 2,200 shares. The Purchase Agreement restricted the Company’s use of any proceeds of the issuances of the Series O Preferred Stock, including to payroll and legal and accounting expenses.


The shares of Series O Preferred Stock were issued in the second closing in reliance on the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and by Rule 506 of Regulation D promulgated thereunder as a transaction by an issuer not involving any public offering.


Item 3.02. Unregistered Sales of Equity Securities.


The information set forth in Item 1.01 is incorporated herein by reference.


Item 8.01. Other Events.


On December 3, 2021, the Company announced that the application by its hospital, Scott County Community Hospital, Inc. (DBA Big South Fork) in Oneida, Tennessee, for designation as a Critical Access Hospital has been approved by the Centers for Medicare and Medicaid Services.


As a result of conversions of shares of the Company’s preferred stock, the Company had 37,189,999,999 shares of common stock issued and outstanding as of December 9, 2021.


Item 9.01. Financial Statements and Exhibits.


Number   Description
99.1   Press Release, dated December 3, 2021
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: December 13, 2021 RENNOVA HEALTH, INC.
  By: /s/ Seamus Lagan
    Seamus Lagan
    Chief Executive Officer
    (principal executive officer)



Rennova Health (PK) (USOTC:RNVA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Rennova Health (PK) Charts.
Rennova Health (PK) (USOTC:RNVA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Rennova Health (PK) Charts.